IVI and Bharat Biotech launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica EP News Bureau Aug 25, 2021 IVI is advancing clinical development of BBV87 through a phase-II/III randomised, controlled trial to evaluate the safety and…
